InsiderTrades

Form 4 for IMAX IMAX CORP

Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-10 · accession 0001214659-25-016179 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-10 2025-11-10 IMAX WELTON MARK Pres IMAX Gbl Theatres C - Cnv Deriv $22.49 +49.5K 202.8K +32% +$1.11M
D 2025-11-10 2025-11-10 IMAX WELTON MARK Pres IMAX Gbl Theatres S - Sale $35.23 -49.5K 153.3K -24% -$1.74M
D 2025-11-10 2025-11-10 IMAX WELTON MARK Pres IMAX Gbl Theatres C - Cnv Deriv $22.49 -49.5K 0 -100% -$1.11M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common common shares 2025-11-10 C A 49,504 $22.49 202,827 D — — (F1) Represents the conversion upon exercise of stock options into common shares.
2 Common common shares 2025-11-10 S D 49,504 $35.23 153,323 D — —
3 Derivative stock options (to buy) 2025-11-10 C D 49,504 $22.49 0 D $22.49 · — to 2026-03-07 49,504 common shares (F2) These options were issued in 2019 and are set to expire on March 7, 2026. (F4) Mr. Welton's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 70,609 and 153,323, respectively. (F3) The stock options became exercisable in four installments: 9,900 on March 7, 2020, 12,376 on each of March 7, 2021 and March 7, 2022 and 14,852 on March 7, 2023.